VERA KARAMFILOVA; YAVOR ASSYOV; IVETA NEDEVA; ANTOANETA GATEVA; IRENA IVANOVA; NIKOLAY CHERKEZOV; LUDMILA MATEVA; ZDRAVKO KAMENOV. Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease. Turkish Journal of Gastroenterology, [S. l.], v. 33, n. 3, p. 233–239, 2022. Disponível em: https://turkjgastroenterol.avesjournals.com/index.php/tjg/article/view/4204. Acesso em: 18 jul. 2025.